Loading...
Loading...
Jyong Biotech Ltd.
Jyong Biotech Ltd.. Spoken Alpha tracks MENS's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks MENS's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 7/10 quarters but stock falls 80% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for MENS.
curl https://api.spokenalpha.com/v1/companies/MENS| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $4.11 | $3.96 | +3.9% | +2.8% | +3.7% |
| Q4 FY2026 | $4.30 | $4.08 | +5.5% | -2.1% | -3.0% |
| Q3 FY2026 | $3.95 | $4.03 | -2.1% | -0.8% | +1.6% |
| Q2 FY2026 | $4.27 | $4.08 | +4.6% | -7.0% | -6.6% |
| Q1 FY2025 | $4.25 | $4.04 | +5.3% | -0.6% | -0.4% |
| Q4 FY2025 | $4.09 | $4.19 | -2.5% | -0.4% | -0.1% |
| Q3 FY2025 | $4.21 | $4.18 | +0.6% | +2.6% | -0.2% |
| Q2 FY2025 | $4.25 | $4.28 | -0.6% | -5.5% | -7.8% |
| Q1 FY2024 | $4.68 | $4.35 | +7.6% | -2.5% | -1.2% |
| Q4 FY2024 | $4.36 | $4.31 | +1.1% | -5.3% | -5.8% |